Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $159,806 | $22,191,000 | $22,661,000 | $23,203,000 |
| % Growth | -99.3% | -2.1% | -2.3% | – |
| Cost of Goods Sold | $81,336 | $11,111,000 | $11,714,000 | $11,483,000 |
| Gross Profit | $78,470 | $11,080,000 | $10,947,000 | $11,720,000 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $138,945 | $8,971,000 | $9,411,000 | $9,264,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1,000 | $1,000 | -$1,000 |
| Operating Expenses | $138,945 | $8,972,000 | $9,412,000 | $9,263,000 |
| Operating Income | -$60,475 | $2,108,000 | $1,535,000 | $2,457,000 |
| % Margin | -37.8% | 9.5% | 6.8% | 10.6% |
| Other Income/Exp. Net | $85,237 | $3,639,000 | $2,502,000 | $1,957,000 |
| Pre-Tax Income | $24,762 | $5,747,000 | $4,037,000 | $4,414,000 |
| Tax Expense | $2,062 | $1,227,000 | $916,000 | $811,000 |
| Net Income | $22,078 | $4,519,000 | $3,121,000 | $3,591,000 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS | 0.53 | 107.87 | 72.91 | 82.99 |
| % Growth | -99.5% | 47.9% | -12.1% | – |
| EPS Diluted | 0.53 | 107.87 | 72.91 | 82.99 |
| Weighted Avg Shares Out | 41,453 | 41,892 | 42,805 | 43,272 |
| Weighted Avg Shares Out Dil | 41,453 | 41,892 | 42,805 | 43,272 |
| Supplemental Information | – | – | – | – |
| Interest Income | $250 | $686,000 | $115,000 | $587,000 |
| Interest Expense | $47 | $0 | $0 | $0 |
| Depreciation & Amortization | $7,882 | $1,153,750 | $1,153,750 | $1,063,500 |
| EBITDA | $32,698 | $3,262,750 | $2,689,750 | $3,519,500 |
| % Margin | 20.5% | 14.7% | 11.9% | 15.2% |